Address
Email address
Phone number
https://estigen.comEstigen - Tissue Microarrayers - EstigenManual Tissue Arrayer MTA-1Automated Tissue Arrayer ATA-27 Previous slide Next slide ESTIGEN – THE BEST TOOLS FOR TISSUE MICROARRAY TECHNOLOGY Estigen OÜ manufactures cutting-edge tissue microarray equipment developed by Beecher Instruments. TISSUE MICROARRAYERS Manual and Automated Tissue Arrayers are available to match customer needs in various application areas. Manual Tissue Arrayer MTA-1 The Manual Tissue […]
Name
Estigen OÜ
Registry code
11999357
VAT number
EE101414391
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
29.09.2010 (13)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
26511 - Manufacture of instruments and appliances for measuring, testing and navigation
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Meelis Kolmer 24.12.1961 (62) | 100% - 2 556.00 EUR | Board member | Direct ownership | Founder |
| 2019 10.09.2020 | 2020 29.06.2021 | 2021 02.07.2022 | 2022 02.08.2023 | |
|---|---|---|---|---|
| Total Revenue | 220 352 € | 163 477 € | 196 052 € | 275 541 € |
| Net profit (loss) for the period | 15 714 € | -5 897 € | 65 718 € | -8 194 € |
| Profit Margin | 7% | -4% | 34% | -3% |
| Current Assets | 183 248 € | 151 374 € | 206 243 € | 186 608 € |
| Fixed Assets | 86 147 € | 62 853 € | 51 011 € | 39 566 € |
| Total Assets | 269 395 € | 214 227 € | 257 254 € | 226 174 € |
| Current Liabilities | 22 199 € | 5 500 € | 8 300 € | 7 734 € |
| Non Current Liabilities | 53 151 € | 52 552 € | 51 899 € | 51 192 € |
| Total Liabilities | 75 350 € | 58 052 € | 60 199 € | 58 926 € |
| Share Capital | - | - | - | - |
| Equity | 194 045 € | 156 175 € | 197 055 € | 167 248 € |
| Employees | 1 | 1 | 1 | 1 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 11 718.45 € | 6 699.99 € | 6 769.94 € | - |
| 2023 Q4 | 53 634.52 € | 8 791.31 € | 8 713.31 € | - |
| 2023 Q3 | 33 086.7 € | 8 465.9 € | 8 615.46 € | - |
| 2023 Q2 | 24 925.42 € | 8 591.06 € | 8 653.09 € | - |
| 2023 Q1 | 32 790.78 € | 9 437.18 € | 8 936.3 € | - |
| 2022 Q4 | 84 613.16 € | 9 755.62 € | 9 047.8 € | - |
| 2022 Q3 | 49 740.54 € | 10 231.72 € | 9 190.81 € | - |
| 2022 Q2 | 99 959.4 € | 10 231.34 € | 9 153.18 € | - |
| 2022 Q1 | 59 122.25 € | 7 598.7 € | 6 767.94 € | - |
| 2021 Q4 | 45 533.51 € | 7 967.13 € | 6 877.55 € | - |
| 2021 Q3 | 34 736.69 € | 8 053.15 € | 7 148.69 € | - |
| 2021 Q2 | 69 659.02 € | 7 573.51 € | 6 785.58 € | - |
| 2021 Q1 | 42 110.77 € | 6 639.71 € | 4 855.4 € | 1 |
| 2020 Q4 | 46 456.82 € | 4 890.81 € | 4 329.56 € | 1 |
| 2020 Q3 | 54 479.95 € | 7 381.16 € | 5 217.31 € | 1 |
| 2020 Q2 | 39 002.18 € | 7 881.79 € | 5 367.85 € | 1 |
| 2020 Q1 | 98 891.87 € | 4 907.77 € | 3 826.58 € | 1 |
